Chartis Announces Majority Investment from Blackstone to Advance Mission of Healthcare Transformation
Chartis, a leading healthcare advisory firm, has announced a majority investment from Blackstone to support its continued growth and mission of healthcare transformation. The investment includes continued equity participation from Audax Private Equity. Blackstone's investment will enable Chartis to:
- Extend its capabilities across strategic, digital, technology, clinical, and financial transformation offerings
- Expand the Chartis family of companies
- Enhance infrastructure and grow organic offerings
The transaction is expected to close by the end of 2024, subject to customary conditions and regulatory approvals. This partnership aims to reshape healthcare, making it more accessible, affordable, reliable, equitable, and human-centered.
Chartis, una delle principali società di consulenza nel settore sanitario, ha annunciato un investimento di maggioranza da parte di Blackstone per supportare la sua continua crescita e la missione di trasformazione sanitaria. L'investimento include la partecipazione azionaria continua di Audax Private Equity. L'investimento di Blackstone consentirà a Chartis di:
- Estendere le proprie capacità nei settori della trasformazione strategica, digitale, tecnologica, clinica e finanziaria
- Espandere la famiglia di aziende Chartis
- Migliorare l'infrastruttura e far crescere le offerte organiche
Si prevede che la transazione si chiuda entro la fine del 2024, soggetta a condizioni consuete e approvazioni normative. Questa partnership mira a rimodellare il settore sanitario, rendendolo più accessibile, conveniente, affidabile, equo e incentrato sull'uomo.
Chartis, una de las principales empresas de asesoría en salud, ha anunciado una inversión mayoritaria de Blackstone para apoyar su continuo crecimiento y misión de transformación sanitaria. La inversión incluye la participación continua de Audax Private Equity. La inversión de Blackstone permitirá a Chartis:
- Ampliar sus capacidades en ofertas de transformación estratégica, digital, tecnológica, clínica y financiera
- Expandir la familia de empresas Chartis
- Mejorar la infraestructura y aumentar las ofertas orgánicas
Se espera que la transacción se cierre a finales de 2024, sujeta a condiciones habituales y aprobaciones regulatorias. Esta asociación tiene como objetivo reconfigurar la atención médica, haciéndola más accesible, asequible, confiable, equitativa y centrada en el ser humano.
Chartis는 주요 의료 자문 회사로서 블랙스톤으로부터의 다수 투자를 발표하여 지속적인 성장과 의료 혁신 사명을 지원합니다. 이번 투자는 Audax Private Equity의 지속적인 지분 참여를 포함합니다. 블랙스톤의 투자를 통해 Chartis는:
- 전략적, 디지털, 기술적, 임상적 및 재무적 변혁 제공 능력을 확대
- Chartis의 기업 가족을 확장
- 인프라를 향상시키고 유기적인 서비스 확대
이번 거래는 관례적인 조건과 규제 승인에 따라 2024년 말까지 마무리될 것으로 예상됩니다. 이번 파트너십은 의료 서비스를 재구성하여 보다 접근 가능하고, 저렴하며, 신뢰할 수 있고, 공정하며, 인간 중심으로 만들기 위한 것입니다.
Chartis, une entreprise de conseil en santé de premier plan, a annoncé un investissement majoritaire de Blackstone pour soutenir sa croissance continue et sa mission de transformation du secteur de la santé. L'investissement comprend une participation continue d'Audax Private Equity. Cet investissement de Blackstone permettra à Chartis de:
- Élargir ses capacités dans les domaines des offres de transformation stratégique, numérique, technologique, clinique et financière
- Développer la famille d'entreprises Chartis
- Améliorer l'infrastructure et accroître les offres organiques
La transaction devrait être conclue d'ici la fin de 2024, sous réserve des conditions habituelles et des approbations réglementaires. Ce partenariat vise à redéfinir le secteur de la santé, le rendant plus accessible, abordable, fiable, équitable et centré sur l'humain.
Chartis, ein führendes Beratungsunternehmen im Gesundheitswesen, hat eine Mehrheitsinvestition von Blackstone angekündigt, um sein kontinuierliches Wachstum und seine Mission der Gesundheitsreform zu unterstützen. Die Investition umfasst die fortdauernde Eigenkapitalbeteiligung von Audax Private Equity. Die Investition von Blackstone wird es Chartis ermöglichen:
- Seine Fähigkeiten in den Bereichen strategische, digitale, technologische, klinische und finanzielle Transformation zu erweitern
- Die Chartis-Familie von Unternehmen zu vergrößern
- Die Infrastruktur zu verbessern und organische Angebote auszubauen
Die Transaktion wird voraussichtlich bis Ende 2024 abgeschlossen sein, vorbehaltlich der üblichen Bedingungen und behördlichen Genehmigungen. Diese Partnerschaft zielt darauf ab, das Gesundheitswesen neu zu gestalten, um es zugänglicher, erschwinglicher, zuverlässiger, gerechter und menschenzentrierter zu machen.
- Majority investment from Blackstone to support Chartis' growth and capabilities expansion
- Continued equity participation from Audax Private Equity
- Potential for enhanced resources and infrastructure to better serve healthcare clients
- Opportunity to expand Chartis' family of companies and service offerings
- None.
Insights
Blackstone's majority investment in Chartis marks a significant development in the healthcare advisory sector. This move is likely to bolster Chartis' market position and expand its service offerings. The deal, expected to close by end of 2024, involves continued equity participation from Audax Private Equity, suggesting a vote of confidence in Chartis' potential.
Notably, Blackstone's investment comes through its core private equity strategy, which typically involves longer holding periods. This approach could provide Chartis with stable, long-term capital to fuel growth and innovation. The undisclosed deal terms and the involvement of major financial advisors like Goldman Sachs hint at a substantial transaction value.
For investors, this deal signals growing private equity interest in healthcare advisory firms, potentially driving up valuations in this sector. The partnership could lead to enhanced revenue streams and market share for Chartis, making it a more formidable player in the healthcare consulting landscape.
This investment underscores the increasing complexity and transformation in the US healthcare system. Chartis' focus on strategic, digital, clinical and financial transformation aligns with the industry's pressing needs. The infusion of Blackstone's resources could accelerate Chartis' ability to address critical challenges like accessibility, affordability and equity in healthcare delivery.
The expansion of Chartis' capabilities, including its family of companies like HealthScape Advisors and Jarrard, suggests a comprehensive approach to healthcare consulting. This could position Chartis to offer more integrated solutions, potentially improving outcomes across the healthcare value chain.
For the broader healthcare sector, this deal might catalyze increased innovation and adoption of next-generation technologies and care models. It also highlights the growing importance of data-driven, strategic advisory services in navigating the complex healthcare landscape, which could lead to more efficient and effective healthcare delivery systems.
Blackstone's investment in Chartis reflects a broader trend of private equity firms targeting healthcare advisory companies. This move suggests growing confidence in the long-term value and growth potential of specialized healthcare consultancies. The deal could trigger a wave of similar investments or consolidations in the sector, potentially reshaping the competitive landscape.
Chartis' expansion plans, including enhancing its organic offerings and infrastructure, indicate a strategic focus on scalability and service diversification. This could lead to increased market share and potentially higher barriers to entry for competitors. The company's emphasis on research and addressing healthcare vulnerabilities aligns with growing demand for data-driven, specialized healthcare solutions.
For market watchers, this deal signals the increasing importance of advisory firms in driving healthcare transformation. It may lead to heightened investor interest in companies operating at the intersection of healthcare, technology and strategic consulting, potentially influencing market trends and valuations in related sectors.
“Chartis was founded with the mission to help clients fundamentally improve healthcare delivery across
“Blackstone’s expertise, scale, and resources align well with Chartis’ transformative vision for the future of the industry,” said Greg Maddrey, President of Chartis. “This investment will provide us with the resources to grow our organic offerings, expand our capabilities, and further enhance our infrastructure. We are excited about the future and confident that this partnership will help us enable our clients to reshape healthcare for the better.”
“The increasing complexity of the healthcare landscape has only amplified the need for trusted partners like Chartis,” said Ram Jagannath, a Senior Managing Director at
Since Audax’ 2019 investment, Chartis has acquired and integrated seven add-on acquisitions, expanding the firm into complementary capabilities and new end markets. During this period, Chartis has also established several new centers for research and advancement, which contribute to better understanding and addressing healthcare where it is most vulnerable.
“Our investment in Chartis is emblematic of our Buy & Build strategy, backing a first-class management team, understanding and collaborating around their vision for growth, and bringing capital and resources to bear to help the company execute on its purpose-driven strategy,” said Audax Private Equity Partner and Co-President Young Lee. “We sincerely thank Ken, Ethan, Greg, and the rest of the Chartis team for their continued partnership.”
The transaction is expected to close by the end of 2024, subject to customary closing conditions and regulatory approvals. Terms of the transaction were not disclosed.
Lincoln International and BofA Securities served as financial advisors, and Ropes and Gray and Winston & Strawn LLP served as legal counsel to Chartis and Audax Private Equity. Goldman Sachs & Co. LLC served as financial advisor and Kirkland & Ellis LLP served as legal counsel to
About Chartis
The challenges facing US healthcare are longstanding and all too familiar. We are Chartis, and we believe in better. We work with more than 900 clients annually to develop and activate transformative strategies, operating models, and organizational enterprises that make US healthcare more affordable, accessible, safe, and human. With more than 1,000 professionals, we help providers, payers, technology innovators, retail companies, and investors create and embrace solutions that tangibly and materially reshape healthcare for the better. Our family of brands—Chartis, Jarrard, Greeley, and HealthScape Advisors—is
About
About Audax Private Equity
Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240814816896/en/
Media Contacts
Chartis
Amy
anorwalk@chartis.com
Thomas J. Rozycki, Jr. / John Perilli / Jack McCarthy
Prosek Partners for Chartis
Pro-Chartis@prosek.com
Matt Anderson
matthew.anderson@blackstone.com
(518) 248-7310
Mariel Seidman-Gati
mariel.seidmangati@blackstone.com
(917) 698-1674
Source:
FAQ
What is the significance of Blackstone's investment in Chartis for the healthcare industry?
How will the Blackstone investment impact Chartis' growth strategy?
When is the Blackstone-Chartis transaction expected to close?
What role will Audax Private Equity play following Blackstone's investment in Chartis?
